Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.

Revenue
+9.98%
EPS
+29.4%
Free cash flow
+6.21%
Total debt
−2.20%

Quarter to September 2026, against a year earlier

256.25 1.51 +0.59%
Market cap
$28.0B
P/E
25.0×
Fwd P/E
24.4×
Dividend yield
1.33%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
20.23 17.57 15.45 16.79 11.24 10.90 19.33 18.55 19.39 19.56
Piotroski F-Score
5 7 5 7 9 8 4 5 4 8
P/S ratio
1.79 1.83 1.50 1.85 1.69 2.00 1.83 1.70 1.70 1.75
Altman Z-Score
3.53 3.51 3.16 3.06 3.50 4.06 3.65 3.09 2.79 3.15
Altman Z″-Score (non-manufacturers)
4.24 4.05 3.83 3.81 4.70 4.44 3.93 3.78 3.31 3.53
P/FCF ratio
15.73 14.68 13.86 16.97 10.06 11.82 13.75 18.25 18.42 14.17
Beneish M-Score
(2.57) (2.63) (2.54) (2.61) (2.30) (2.58) (2.85) (2.56) (2.54) (2.65)
P/Operating CF
36.87 41.95 38.39 41.12 29.52 44.96 54.10 29.93 36.09 41.42
Dividend Safety Score
— — — — — — — — — 85
P/B ratio
2.78 2.73 2.15 2.52 2.35 3.34 3.05 2.49 2.46 2.67
EV/Sales
2.26 2.32 2.00 2.32 1.99 2.30 2.20 2.14 2.27 2.22
EV/EBITDA
10.69 11.98 10.70 11.47 8.07 8.88 11.65 11.64 12.19 11.53
EV/FCF
19.83 18.63 18.46 21.22 11.86 13.53 16.54 22.92 24.66 18.04
Current Ratio
1.56 1.24 0.94 1.25 1.72 1.56 1.22 1.31 1.10 1.04
Net Debt/EBITDA
2.21 2.54 2.67 2.29 1.23 1.13 1.97 2.37 3.08 2.47
Debt/Equity
0.80 0.76 0.74 0.84 0.59 0.62 0.67 0.74 0.91 0.79
ROE
13.70% 16.06% 14.40% 15.67% 22.81% 29.91% 15.18% 13.85% 13.17% 14.10%
ROA
6.40% 7.49% 6.84% 7.20% 10.61% 14.39% 7.12% 6.33% 5.74% 6.10%
ROIC
9.93% 8.46% 7.62% 8.30% 12.74% 15.46% 9.30% 7.61% 6.74% 7.81%
Return on Tangible Assets
40.66% 55.38% 61.69% 43.93% 48.99% 73.77% 44.58% 35.82% 37.07% 42.90%
Average Days of Receivables
46.85 45.56 49.05 50.22 58.79 48.65 44.13 47.74 48.21 46.57
Earnings Yield
4.94% 5.69% 6.47% 5.96% 8.89% 9.17% 5.17% 5.39% 5.16% 5.11%
Free Cash Flow Yield
6.36% 6.81% 7.21% 5.89% 9.94% 8.46% 7.27% 5.48% 5.43% 7.06%
Free Cash Flow per Share
5.88 6.74 6.01 6.29 11.84 14.64 11.33 7.71 8.19 12.24
Book value per Share
33.29 36.17 38.73 42.44 50.81 51.86 51.12 56.63 61.38 64.92
Free Cash Flow
823.00 923.00 817.00 843.00 1,587.00 1,830.00 1,314.00 864.00 909.00 1,359.00
EV/EBIT
12.78 14.76 13.70 14.53 9.55 10.40 15.22 15.69 16.65 15.75
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026